№ lp_1_2_36457
File format: docx Character count: 121278 File size: 289 KB
The document outlines the solicitation for project proposals related to the development of small molecule therapeutics for COVID-19, specifically aimed at Pre-exposure Prophylaxis (PrEP) against SARS-CoV-2 variants, under the Biomedical Advanced Research and Development Authority (BARDA) initiative.
Year: 2024
Region / city: United States
Subject: COVID-19 therapeutics development
Document type: Request for Proposals (RFP)
Organ / institution: Biomedical Advanced Research and Development Authority (BARDA)
Author: Biomedical Advanced Research and Development Authority (BARDA)
Target audience: Product developers, biomedical organizations
Period of validity: 2024–2027
Approval date: 05 August 2024
Amendment date: 20 August 2024
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Ashim Subedee: Director of Catalyst Office at BARDA
Year: 2026
Region / City: United States, Washington D.C.
Theme: Health Security Innovation, Biomedical Research
Document Type: Biography
Organization: Biomedical Research & Development Authority (BARDA)
Author: Ashim Subedee
Target Audience: Researchers, Health Innovators, Policy Makers
Date of Approval: N/A
Date of Changes: N/A
Biomedical Advanced Research and Development Authority (BARDA) Request for Project Proposals (RPP) for “Rapid Pandemic Influenza and Emerging Infectious Disease Vaccine Development and Response Capability” RPP #: RRPV-24-08-mRNALongTerm Amendment 02
Year: 2024
Region / City: United States
Subject: Pandemic influenza, vaccine development, emerging infectious diseases
Document Type: Request for Proposals (RFP)
Organization: Biomedical Advanced Research and Development Authority (BARDA)
Author: BARDA
Target Audience: Product developers, medical and pharmaceutical industry
Period of Validity: 2024–2025
Date of Approval: August 30, 2024
Date of Amendments: October 28, 2024, November 19, 2024
Topics: 24-03-SmMol RRPV BARDA